GRIN1 p.Ala349Ser

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP6

The NM_007327.4(GRIN1):​c.1045G>T​(p.Ala349Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000992 in 1,613,368 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A349T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000059 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00010 ( 0 hom. )

Consequence

GRIN1
NM_007327.4 missense

Scores

12
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:2

Conservation

PhyloP100: 9.20

Publications

4 publications found
Variant links:
Genes affected
GRIN1 (HGNC:4584): (glutamate ionotropic receptor NMDA type subunit 1) The protein encoded by this gene is a critical subunit of N-methyl-D-aspartate receptors, members of the glutamate receptor channel superfamily which are heteromeric protein complexes with multiple subunits arranged to form a ligand-gated ion channel. These subunits play a key role in the plasticity of synapses, which is believed to underlie memory and learning. Cell-specific factors are thought to control expression of different isoforms, possibly contributing to the functional diversity of the subunits. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2008]
GRIN1 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
  • neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, MODERATE Submitted by: Ambry Genetics, G2P
  • developmental and epileptic encephalopathy 101
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_007327.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BP6
Variant 9-137158455-G-T is Benign according to our data. Variant chr9-137158455-G-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 539843.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_007327.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIN1
NM_007327.4
MANE Select
c.1045G>Tp.Ala349Ser
missense
Exon 7 of 20NP_015566.1Q05586-1
GRIN1
NM_001437330.1
c.1108G>Tp.Ala370Ser
missense
Exon 8 of 21NP_001424259.1
GRIN1
NM_001185090.2
c.1108G>Tp.Ala370Ser
missense
Exon 8 of 21NP_001172019.1Q05586-6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIN1
ENST00000371561.8
TSL:1 MANE Select
c.1045G>Tp.Ala349Ser
missense
Exon 7 of 20ENSP00000360616.3Q05586-1
GRIN1
ENST00000371553.8
TSL:1
c.1108G>Tp.Ala370Ser
missense
Exon 8 of 21ENSP00000360608.3Q05586-6
GRIN1
ENST00000371560.5
TSL:1
c.1108G>Tp.Ala370Ser
missense
Exon 8 of 20ENSP00000360615.3Q05586-7

Frequencies

GnomAD3 genomes
AF:
0.0000592
AC:
9
AN:
152088
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000957
AC:
24
AN:
250828
AF XY:
0.0000736
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000202
Gnomad ASJ exome
AF:
0.000199
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000124
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000103
AC:
151
AN:
1461280
Hom.:
0
Cov.:
33
AF XY:
0.000110
AC XY:
80
AN XY:
726918
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.000224
AC:
10
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000115
AC:
3
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52898
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.000117
AC:
130
AN:
1111936
Other (OTH)
AF:
0.000132
AC:
8
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
10
20
29
39
49
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000592
AC:
9
AN:
152088
Hom.:
0
Cov.:
33
AF XY:
0.0000269
AC XY:
2
AN XY:
74294
show subpopulations
African (AFR)
AF:
0.0000483
AC:
2
AN:
41392
American (AMR)
AF:
0.000196
AC:
3
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68026
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.569
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000614
Hom.:
0
Bravo
AF:
0.000128
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
1
not provided (2)
-
1
-
Inborn genetic diseases (1)
-
-
1
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant (1)
-
1
-
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.088
T
BayesDel_noAF
Uncertain
-0.080
CADD
Pathogenic
29
DANN
Uncertain
1.0
DEOGEN2
Benign
0.41
T
Eigen
Uncertain
0.48
Eigen_PC
Uncertain
0.49
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.97
D
M_CAP
Uncertain
0.15
D
MetaRNN
Uncertain
0.57
D
MetaSVM
Uncertain
0.065
D
MutationAssessor
Benign
1.4
L
PhyloP100
9.2
PrimateAI
Uncertain
0.75
T
PROVEAN
Benign
-1.8
N
REVEL
Uncertain
0.59
Sift
Benign
0.13
T
Sift4G
Benign
0.14
T
Varity_R
0.24
gMVP
0.70
Mutation Taster
=48/52
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs148008303;
hg19: chr9-140052907;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.